ArticleBMC cardiovascular disorders2025
Long QT syndrome type 1: clinical and functional characterization of KCNQ1 variant c.1111G > C.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundCongenital long QT syndrome is a clinical disorder of genetic origin characterized by delayed repolarization of the myocardium, electrocardiographic QT prolongation, and increased risk of syncope, and sudden cardiac death due to polymorphic ventricular tachycardia. KCNQ1-related congenital long QT syndrome (LQT1) is the most prevalent of the long QT syndrome genetic subgroups and is typically caused by pathogenic missense or protein-truncating gene variants. Phenotypic features, computational analysis, and electrophysiological characterization of the variant are essential steps in assessing the pathogenicity of DNA variants and contribute to the future management of patients.
methodsWe report the results of the clinical evaluation of five Lithuanian families with a rare pathogenic heterozygous KCNQ1 variant c.1111G > C [p.(Ala371Pro)], including computational Kv7.1 protein structure analysis, molecular dynamics simulations, and electrophysiological characterization of the affected Kv7.1 channel.
resultsThe individuals with the pathogenic variant (n = 9) exhibited phenotypic LQTS features during an exercise stress test (mean QTc during peak exercise was 497 ± 26 ms; mean QTc during the 4th minute of the recovery – 485 ± 22 ms) despite the low penetrance in the resting 12-lead ECG (mean QTc 423 ± 37 ms) or their symptomatic status. The sudden cardiac deaths of two females at the age of 34 years were reported in these families. Molecular dynamics simulations showed that the change p.Ala371Pro might disrupt the structure of the helix A in the Kv7.1 protein. Functional evaluation revealed that the pathogenic variant reduced the conductance of the channel by 46%, while the voltage dependence of activation was not affected.
conclusionsThis is the first functional description of the KCNQ1 variant c.1111G > C that causes LQT1 phenotypic features. The variant is highly suggestive of the risk of disease-related cardiac events, particularly under adrenergic urge.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.